Universe Pharmaceuticals INC (UPC) stock
UPCNasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Sep 30, 2025Last filing: 20-F on Jan 29, 2026Score 5/30
$1.52−0.04 (-2.48%)
Close on Nov 18, 2026Market cap $857.01KP/E –Yield –
Universe Pharmaceuticals operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2025 it was -$2.92B. The highest annual figure on record is $13.59M in fiscal 2021.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -$2.92B | – |
| FY2024 | Sep 30, 2024 | -$8.02B | – |
| FY2023 | Sep 30, 2023 | -$3.97B | – |
| FY2022 | Sep 30, 2022 | -$7.02M | -151.7% |
| FY2021 | Sep 30, 2021 | $13.59M | +32.6% |
| FY2020 | Sep 30, 2020 | $10.25M | +5.1% |
| FY2019 | Sep 30, 2019 | $9.75M | – |
See a number that looks wrong?